Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: a systematic review and meta-analysis.

Cardio-Oncology
Meer Rabeel ZafarUmesh C Sharma

Abstract

Cancer survivors with prior chest radiation therapy (C-XRT) frequently present with aortic stenosis (AS) as the first manifestation of radiation-induced heart disease. They are considered high-risk for surgical valve replacement. Transcatheter aortic valve replacement (TAVR) is as an attractive option for this patient population but the outcomes are not well established in major clinical trials. The authors performed a systemic review and meta-analysis of clinical studies for the outcomes after TAVR in cancer survivors with prior C-XRT. Online databases were searched from inception to April 2020 for studies evaluating the outcomes of TAVR in patients with and without C-XRT. We analyzed the pooled estimates (with their 95% confidence intervals) of the odds ratio (OR) for the all-cause mortality at 30-day and 1-year follow-ups, 4-point safety outcomes (stroke, major bleed, access-related vascular complications and need for a pacemaker), a 2-point efficacy outcome (mean aortic valve gradient and left ventricular ejection fraction) and worsening of congestive heart failure (CHF). Four studies were included following 2054 patients with and without prior C-XRT exposure (164 patients and 1890 patients respectively). The C-XRT group ha...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Dec 6, 2003·JAMA : the Journal of the American Medical Association·Matthew C HullNancy Price Mendenhall
Aug 7, 2004·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Kazuyuki DaitokuIkuo Fukuda
Jan 18, 2006·Annual Review of Medicine·Edward T H Yeh
Apr 21, 2007·General Thoracic and Cardiovascular Surgery·Atsushi TamuraMasayoshi Katsumata
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Jan 22, 2011·Journal of the American College of Cardiology·Kim BouillonFlorent de Vathaire
Aug 20, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Miriam PulsWolfgang Schillinger
Mar 6, 2015·Frontiers in Oncology·Neil K TaunkSharad Goyal
Mar 10, 2015·The Journal of Thoracic and Cardiovascular Surgery·Srisakul ChirakarnjanakornMilind Y Desai
May 6, 2015·Pacing and Clinical Electrophysiology : PACE·Abhishek MaanMoussa Mansour
Jun 22, 2016·The American Journal of Cardiology·Yusuke WatanabeKentaro Hayashida
Nov 23, 2017·Journal of Interventional Cardiology·Norman MangnerAxel Linke
Jul 15, 2018·Current Problems in Cancer·Merna A ArmaniousMichael G Fradley
Nov 9, 2018·Frontiers in Cardiovascular Medicine·Ozan M DemirAzeem Latib
Dec 24, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Omar El-SherifStewart Gaede
Jan 10, 2019·JACC. Cardiovascular Interventions·Uri LandesRan Kornowski
May 14, 2019·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Deepakraj GajananaRon Waksman
Jan 14, 2020·The American Journal of Cardiology·Justin M CanadaAntonio Abbate
Jan 22, 2020·Journal of the American Heart Association·Avirup GuhaDaniel Addison

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

RevMan
Review Manager (

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.